Pacira BioSciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pacira BioSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Pacira BioSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$143M, a 1421% decline year-over-year.
  • Pacira BioSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$90.7M, a 1399% decline year-over-year.
  • Pacira BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $42M, a 164% increase from 2022.
  • Pacira BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $15.9M, a 62.1% decline from 2021.
  • Pacira BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $42M, a 71.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$90.7M -$143M -$154M -1421% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $63.6M $18.9M -$6.88M -26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $70.5M $8.98M +$28.5M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $42M $24.9M +$35M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $6.98M $10.9M +$11.6M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$4.57M $25.8M +$5.89M +29.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$10.5M -$19.5M -$26.4M -386% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $15.9M -$10.1M -$4.97M -96.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $20.9M -$693K -$18.4M -104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $39.2M $19.9M +$795K +4.17% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $38.4M $6.83M -$3.54M -34.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $42M -$5.13M -$19.6M -135% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $61.6M $17.7M -$112M -86.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $174M $19.1M +$26.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $148M $10.4M +$2.21M +27.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $146M $14.5M +$19.4M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $126M $130M +$136M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$10.1M -$7.27M -$10M -366% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$86K $8.16M +$10.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$11M -$4.89M -$13.2M -159% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.16M -$6.09M -$5.45M -851% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $7.6M $2.73M +$166K +6.47% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $7.44M -$2.77M +$7.91M +74.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$471K $8.29M +$3.69M +80.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 -$4.16M -$640K +$6.96M +91.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 -$11.1M $2.56M +$22.3M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 -$33.4M -$10.7M +$9.19M +46.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 -$42.6M $4.6M +$8.57M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$51.2M -$7.6M +$14.6M +65.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$65.7M -$19.7M -$11.8M -148% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$54M -$19.9M -$16M -415% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$37.9M -$3.97M -$1.48M -59% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 -$36.5M -$22.2M -$25.3M -818% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 -$11.2M -$7.96M -$7.97M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 -$3.26M -$3.85M -$5.11M -406% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $1.86M -$2.5M +$11.2M +81.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$9.36M $3.09M +$6.09M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$15.5M $8K* +$5.05M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$20.5M $1.26M +$12.7M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$33.2M -$13.7M -$1.76M -14.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$31.5M -$3M +$11.8M +79.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 -$43.3M -$5.04M +$8.99M +64.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 -$52.2M -$11.5M +$11.7M +50.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 -$63.9M -$12M +$4.39M +26.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 -$68.3M -$14.8M +$961K +6.1% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 -$69.3M -$14M -$5.74M -69.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 -$63.5M -$23.1M -$11.2M -94.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 -$52.3M -$16.3M -$1.06M -6.96% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 -$51.2M -$15.7M -$6.24M -65.6% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 -$45M -$8.3M +$467K +5.33% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 -$45.4M -$11.9M -$2.12M -21.7% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 -$43.3M -$15.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 -$9.51M -$1.61M -20.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$8.76M -$1.95M -28.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$9.78M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$7.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$6.81M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.